Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 17, 2021

SELL
$6.21 - $48.36 $171,675 - $1.34 Million
-27,645 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$7.21 - $9.37 $55,553 - $72,195
-7,705 Reduced 21.8%
27,645 $210,000
Q1 2020

May 15, 2020

BUY
$3.29 - $9.73 $116,301 - $343,955
35,350 New
35,350 $131,000

About Aptevo Therapeutics Inc.


  • Ticker APVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,090,640
  • Market Cap $24.5M
  • Description
  • Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelo...
More about APVO
Track This Portfolio

Track Worth Venture Partners, LLC Portfolio

Follow Worth Venture Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worth Venture Partners, LLC with notifications on news.